SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019284
Filing Date
2022-05-10
Accepted
2022-05-10 16:17:26
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rna-10q_20220331.htm   iXBRL 10-Q 1437630
2 EX-10.1 rna-ex101_191.htm EX-10.1 177126
3 EX-31.1 rna-ex311_6.htm EX-31.1 10552
4 EX-31.2 rna-ex312_7.htm EX-31.2 10561
5 EX-32.1 rna-ex321_8.htm EX-32.1 6780
6 EX-32.2 rna-ex322_9.htm EX-32.2 6772
  Complete submission text file 0001564590-22-019284.txt   6230172

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rna-20220331.xsd EX-101.SCH 42116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rna-20220331_cal.xml EX-101.CAL 39730
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rna-20220331_def.xml EX-101.DEF 126614
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20220331_lab.xml EX-101.LAB 343516
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20220331_pre.xml EX-101.PRE 256974
54 EXTRACTED XBRL INSTANCE DOCUMENT rna-10q_20220331_htm.xml XML 1169318
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 22909884
SIC: 2834 Pharmaceutical Preparations